title: CD5 expression promotes IL-10 production through activation of the MAPK/Erk pathway and upregulation of TRPC1 channels in B lymphocytes.
abstract: CD5 is constitutively expressed on T cells and a subset of mature normal and leukemic B cells in patients with chronic lymphocytic leukemia (CLL). Important functional properties are associated with CD5 expression in B cells, including signal transducer and activator of transcription 3 activation, IL-10 production and the promotion of B-lymphocyte survival and transformation. However, the pathway(s) by which CD5 influences the biology of B cells and its dependence on B-cell receptor (BCR) co-signaling remain unknown. In this study, we show that CD5 expression activates a number of important signaling pathways, including Erk1/2, leading to IL-10 production through a novel pathway independent of BCR engagement. This pathway is dependent on extracellular calcium (Ca2+) entry facilitated by upregulation of the transient receptor potential channel 1 (TRPC1) protein. We also show that Erk1/2 activation in a subgroup of CLL patients is associated with TRPC1 overexpression. In this subgroup of CLL patients, small inhibitory RNA (siRNA) for CD5 reduces TRPC1 expression. Furthermore, siRNAs for CD5 or for TRPC1 inhibit IL-10 production. These findings provide new insights into the role of CD5 in B-cell biology in health and disease and could pave the way for new treatment strategies for patients with B-CLL.
authors: INSERM ERI29/EA2216, réseau epigenetique and réseau canaux ioniques du Cancéropôle Grand Ouest, Brest University Medical School, Brest 29609, France.
authors: Soizic
authors: S
authors: Garaud
authors: Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK.
authors: Taher E
authors: TE
authors: Taher
authors: INSERM ERI29/EA2216, réseau epigenetique and réseau canaux ioniques du Cancéropôle Grand Ouest, Brest University Medical School, Brest 29609, France.
authors: Marjolaine
authors: M
authors: Debant
authors: Canalopathy and Calcium Signaling, INSERM UMR1078, Brest 29238, France.
authors: Miguel
authors: M
authors: Burgos
authors: INSERM ERI29/EA2216, réseau epigenetique and réseau canaux ioniques du Cancéropôle Grand Ouest, Brest University Medical School, Brest 29609, France.
authors: Sarra
authors: S
authors: Melayah
authors: INSERM ERI29/EA2216, réseau epigenetique and réseau canaux ioniques du Cancéropôle Grand Ouest, Brest University Medical School, Brest 29609, France.
authors: Christian
authors: C
authors: Berthou
authors: Centre for Experimental and Molecular Medicine, Academic Medical Center, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
authors: Kaushal
authors: K
authors: Parikh
authors: INSERM ERI29/EA2216, réseau epigenetique and réseau canaux ioniques du Cancéropôle Grand Ouest, Brest University Medical School, Brest 29609, France.
authors: Jacques-Olivier
authors: JO
authors: Pers
authors: INSERM ERI29/EA2216, réseau epigenetique and réseau canaux ioniques du Cancéropôle Grand Ouest, Brest University Medical School, Brest 29609, France.|Laboratory of Immunology and Immunotherapy, CHU Morvan, Brest 29609, France.
authors: Damien
authors: D
authors: Luque-Paz
authors: Institut Cochin, INSERM U567, Paris 75014, France.
authors: Gilles
authors: G
authors: Chiocchia
authors: Department of Gastroenterology and Hepatology, Erasmus MC, Gravendijkwal 230, Rotterdam, 015 CE, Rotterdam, The Netherlands.
authors: Maikel
authors: M
authors: Peppelenbosch
authors: Centre for Rheumatology, University College London, London WC1E 6JF, UK.
authors: David A
authors: DA
authors: Isenberg
authors: INSERM ERI29/EA2216, réseau epigenetique and réseau canaux ioniques du Cancéropôle Grand Ouest, Brest University Medical School, Brest 29609, France.
authors: Pierre
authors: P
authors: Youinou
authors: Canalopathy and Calcium Signaling, INSERM UMR1078, Brest 29238, France.
authors: Olivier
authors: O
authors: Mignen
authors: INSERM ERI29/EA2216, réseau epigenetique and réseau canaux ioniques du Cancéropôle Grand Ouest, Brest University Medical School, Brest 29609, France.|Laboratory of Immunology and Immunotherapy, CHU Morvan, Brest 29609, France.
authors: Yves
authors: Y
authors: Renaudineau
authors: Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK.
authors: Rizgar A
authors: RA
authors: Mageed
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D001402:B-Lymphocytes / Q000378:metabolism*; D018956:CD5 Antigens / Q000378:metabolism*; D002118:Calcium / Q000378:metabolism; D045744:Cell Line, Tumor; D005260:Female; D006801:Humans; D016753:Interleukin-10 / Q000096:biosynthesis*; D015451:Leukemia, Lymphocytic, Chronic, B-Cell; D020935:MAP Kinase Signaling System; D008297:Male; D008875:Middle Aged; D008954:Models, Biological; D010766:Phosphorylation; D011947:Receptors, Antigen, B-Cell / Q000378:metabolism; D050052:TRPC Cation Channels / Q000378:metabolism*; D059467:Transcriptome / Q000235:genetics; D015854:Up-Regulation
chemical_list: D018956:CD5 Antigens; D011947:Receptors, Antigen, B-Cell; D050052:TRPC Cation Channels; C096351:transient receptor potential cation channel, subfamily C, member 1; D016753:Interleukin-10; D002118:Calcium